Literature DB >> 15801815

Adverse cardiovascular effects of the coxibs.

Jean-Michel Dogné1, Claudiu T Supuran, Domenico Pratico.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15801815     DOI： 10.1021/jm0402059

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  24 in total

1.  Impeding the interaction between Nur77 and p38 reduces LPS-induced inflammation.

Authors:  Li Li; Yuan Liu; Hang-zi Chen; Feng-wei Li; Jian-feng Wu; Hong-kui Zhang; Jian-ping He; Yong-zhen Xing; Yan Chen; Wei-jia Wang; Xu-yang Tian; An-zhong Li; Qian Zhang; Pei-qiang Huang; Jiahuai Han; Tianwei Lin; Qiao Wu
Journal:  Nat Chem Biol       Date:  2015-03-30       Impact factor: 15.040

2.  Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on myocardial function and perfusion.

Authors:  Michael P Robich; Louis M Chu; Thomas A Burgess; Jun Feng; Cesario Bianchi; Frank W Sellke
Journal:  J Cardiovasc Pharmacol       Date:  2011-01       Impact factor: 3.105

3.  2-(2-Arylphenyl)benzoxazole As a Novel Anti-Inflammatory Scaffold: Synthesis and Biological Evaluation.

Authors:  Kapileswar Seth; Sanjeev K Garg; Raj Kumar; Priyank Purohit; Vachan S Meena; Rohit Goyal; Uttam C Banerjee; Asit K Chakraborti
Journal:  ACS Med Chem Lett       Date:  2014-02-17       Impact factor: 4.345

4.  Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study.

Authors:  Souhila Bouaziz-Terrachet; Amel Toumi-Maouche; Boubekeur Maouche; Safia Taïri-Kellou
Journal:  J Mol Model       Date:  2010-03-17       Impact factor: 1.810

5.  Pharmacophore generation and atom-based 3D-QSAR of novel 2-(4-methylsulfonylphenyl)pyrimidines as COX-2 inhibitors.

Authors:  Ujashkumar A Shah; Hemantkumar S Deokar; Shivajirao S Kadam; Vithal M Kulkarni
Journal:  Mol Divers       Date:  2009-08-11       Impact factor: 2.943

6.  Symmetrical bis-tertiary amines as novel CXCR4 inhibitors.

Authors:  Renren Bai; Zhongxing Liang; Younghyoun Yoon; Shuangping Liu; Theresa Gaines; Yoonhyeun Oum; Qi Shi; Suazette Reid Mooring; Hyunsuk Shim
Journal:  Eur J Med Chem       Date:  2016-04-19       Impact factor: 6.514

7.  Synthesis of 5,5-disubstituted butenolides based on a Pd-catalyzed gamma-arylation strategy.

Authors:  Alan M Hyde; Stephen L Buchwald
Journal:  Org Lett       Date:  2009-06-18       Impact factor: 6.005

8.  3,5-Disubstituted Isoxazole Derivatives: Potential Inhibitors of Inflammation and Cancer.

Authors:  Kodagahalli Sathya Rakesh; Swamy Jagadish; Kyathegowdanadoddi Srinivas Balaji; Farhan Zameer; Toreshettahally Ramesh Swaroop; Chakrabhavi Dhanajaya Mohan; Shankar Jayarama; Kanchugarakoppal Subbegowda Rangappa
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

9.  O2-acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): synthesis, nitric oxide release, and biological evaluation studies.

Authors:  Carlos A Velázquez; P N Praveen Rao; Michael L Citro; Larry K Keefer; Edward E Knaus
Journal:  Bioorg Med Chem       Date:  2007-05-06       Impact factor: 3.641

10.  Discovery of trisubstituted pyrazolines as a novel scaffold for the development of selective phosphodiesterase 5 inhibitors.

Authors:  Mohammad Abdel-Halim; Heather Tinsley; Adam B Keeton; Mohammed Weam; Noha H Atta; Mennatallah A Hammam; Amr Hefnawy; Rolf W Hartmann; Matthias Engel; Gary A Piazza; Ashraf H Abadi
Journal:  Bioorg Chem       Date:  2020-09-28       Impact factor: 5.275
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.